A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Lewis, Paula (Project Manager)

Project: Research

StatusActive
Effective start/end date30/10/19 → 31/12/21
View all
View less

Keywords

  • Gastroenterology
  • Primary Sclerosing Cholangitis
  • Clinical trial